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Foreword
This is the Neonatal Therapeutic 
Hypothermia in Ireland report for 2018. It is 
a collaborative initiative undertaken by the 
National Clinical Programme for Paediatrics 
and Neonatology (NCPPN), the National 
Perinatal Epidemiology Centre (NPEC) and 
the National Women and Infants Health 
Programme (NWIHP). The Therapeutic 
Hypothermia steering committee has 
overseen the governance of the project.
We thank all 19 maternity sites in Ireland for 
their willingness to contribute to this project 
and their help with the data collection 
process. This report would not have been 
possible without the valued support of each 
hospital and its staff. 
Work continues to progress in the 
development of the Electronic-Register. It 
is anticipated that the E-Register will be 
in operation from January 2020, whereby 
all 2019 data will be collected using the 
E-Register. Data will be collected using a 
refined dataset, on the E-Register, compared 
to that of the current data collection tool. 
National data collected on the E-Register will 
continue to be analysed from a number of 
perspectives; antenatal, labour management, 
resuscitation of the neonate and the overall 
clinical management of this cohort. The 
NPEC has been instrumental in progressing 
this work.
From 2020 onwards, we will begin the 
collection of national data on the formal 
developmental assessment carried out at 
two years of age. It has been previously 
advocated for and recommended in the 
2016/2017 TH report that all babies who 
require treatment should be followed up for 
their formal developmental assessment. A 
data set has been designed using a Multi-
Disciplinary Team approach to extract 
pertinent data on the developmental data 
of these infants. Once again in our request 
to gain this information hospital sites have 
been very receptive and are demonstrating 
a commitment to assist the Therapeutic 
Hypothermia steering committee on this 
important endeavour.
This report serves as a valuable resource 
to Medical, Midwifery and Nursing staff 
who are striving to make quality changes 
in the services we deliver to mothers 
and their babies. The recently formed 
National Neonatal Encephalopathy Action 
Group reflects this. The group comprises 
representatives from the Department of 
Health, the States Claims Agency, and 
the Health Service Executive, the NWIHP, 
the NPEC, Clinical Leads and patient 
advocates. The group acknowledges the 
long-lasting consequences caused by 
Neonatal Encephalopathy. The group aims 
to reduce avoidable instances of Neonatal 
Encephalopathy through the identification 
of known causes and risk factors and plans 
to drive initiatives to eliminate or mitigate 
them. The aspiration is a reduction in 
cases requiring therapeutic hypothermia 
intervention in our national maternity units/
hospitals. This working group has been 
endorsed by the Minister for Health Mr 
Simon Harris. 
We look forward to working with all 
stakeholders in 2020. 
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Therapeutic Hypothermia (TH) has been 
found to be protective in those infants 
presenting with moderate or severe 
Neonatal Encephalopathy (NE) by inhibiting 
various events in the cascade of this injury. 
The effectiveness of TH in preventing brain 
injury to hypoxic infants is a welcomed 
development, whilst the number need to 
treat remains at 7 (only 1 in 7 will benefit 
from therapy), major Randomised Clinical 
Trials (RCT) involving induced neonatal 
hypothermia have demonstrated a reduction 
in death and disability. The RCTs have shown 
improved outcomes for this cohort of babies 
if they are cooled within 6 hours of birth to a 
targeted core temperature of between 33°C 
- 34°C for a duration of 72 hours. Rewarming 
to normothermic temperature occurs over a 
12-hour period. TH has been considered the 
standard of care since 2009 for infants with 
moderate and severe NE. 
This Report, pertaining to Neonatal 
Therapeutic Hypothermia (TH) serves two 
purposes. Firstly, it documents the maternal 
and infant clinical data for the cases 
requiring TH which occurred in Ireland in 
2018. Secondly, it provides the composite 
data for all TH cases in the three-year period 
2016-2018. The strength of the report is 
that it is based on a geographically defined 
region, namely the Republic of Ireland. All 
cases of TH have been captured. This makes 
the findings representative and eliminates 
selection bias. In 2018, 60% of TH infants 
who received TH were born in one of the 
four tertiary maternity hospitals and 40% of 
TH infants were born in one of the other 15 
maternity hospitals. This is consistent with 
the pattern observed from the composite 
data from 2016-2018. In 2018 there were 
69 TH cases and there were 61,016 births 
nationally. The incidence rate was 1.07 per 
1,000 births; which suggests that one in 
one in every 884 infants born required TH. 
The composite data for 2016-2018 was 209 
TH cases and there were 186,966 births 
nationally in this timeframe amounting to an 
overall incidence of 1.11 per 1,000 births (one 
in every 899 births required TH). 
The annual incidence of TH was consistent 
during 2016-2018. 
•  A Maternity unit with 2,700 births would 
expect to encounter three cases annually.
•  A Maternity unit with 5,400 births would 
have six cases annually.
•  A Maternity unit with 8,100 births would 
anticipate nine cases annually.
These figures provide units with a guide on 
how to benchmark their activity in relation 
to the annual rate of TH cases. 
In 2018 there were seven deaths among the 
69 infants who recieved TH, a mortality rate 
of 10%. The composite number for 2016-
2018 was 24 infants’ deaths, which equates 
to a mortality rate of 12%. NE requiring TH is 
the commonest cause of death in normally 
formed term new-born infants. A unit with 
2,700 births would expect to encounter a 
death from NE once every three years, a 
unit with 5,400 births once every 18 months 
whereas a unit with 8,100 births will have 
one TH death per year. 
In 2018, 18% of TH infants were postnatally 
found to be small for dates. In the composite 
data 2016-2018 19% were born small for 
dates. In 2018 a diagnosis of Intrauterine 
Growth Restriction (IUGR) was made in 7% 
of the TH cases. The composite 2016-2018 
data reported a diagnosis of IUGR in 8% 
of TH cases. These findings demonstrate 
that poor fetal growth is a factor in some 
TH cases. Currently less than half are 
being identified antenatally. The diagnostic 
criterion for IUGR needs to be reviewed and 
the diagnostic rate improved.
In 2018, 57% of TH cases were born to 
primiparous women and 43% born to 
multiparous women. The composite data 
2016/17/18 shows that 59% of TH cases were 
born to primiparous mothers and 41% TH 
cases were born to multiparous women. 
These figures show that the incidence of a 
baby requiring TH in primiparous women is 
1:577 and in multiparous women it is 1:1347. 
This represents a 2.3 times increased risk 
in first time mothers. Recognition of this 
finding should be appreciated by all units 




In 2018, 9% of TH cases were associated with 
assisted reproductive treatment (ART), in 
which 83% of these cases had IVF. As to be 
expected given this cohort, in terms of parity 
the majority of women were nulliparous 
(83%). The composite 2016-2018 data found 
that 7% TH cases had fertility treatment. It is 
estimated that 2.5% of births in Ireland are 
from ART pregnancies. This would mean that 
over the same three year period (2016-2018) 
4,674 births were from ART resulting in the 
TH incidence in this group of 1:311 which 
represents a three-fold increased risk.
In 2018, 9% of TH cases were associated with 
an endocrine disorder in the mother during 
pregnancy which is consistent with the 
findings from the composite data 2016-2018 
at 8%. This finding supports the importance 
that mothers with these disorders need 
frequent thyroid function tests and dosage 
adjustment during the pregnancy in 
perinatal medicine clinics or endocrinology 
clinics.
In 2018, 48% of mothers of infants treated 
with TH laboured spontaneously, 33% were 
induced and 19% were never in labour. 
The composite data for 2016-2018 was: 
Spontaneous labour 49% cases Induction 
34.0% cases and Never in labour 17.2% 
cases. The significant number of TH cases 
in mothers who were never in labour needs 
further investigation.
In 2018, 4% of the TH cases were associated 
with pyrexia in labour. The corresponding 
findings for 2016 and 2017 were 22% of cases 
and 16% of cases. This improvement may in 
part be due to improved knowledge around 
sepsis recognition and treatment.
In 2018, 4% of TH cases were associated with 
a uterine rupture. In the three years 2016-
2018 4% of TH cases occurred secondary to 
a uterine rupture. Previous caesarean section 
and uterine rupture in the subsequent labour 
is a recognised entity; the woman should 
be clearly counselled about these risks to 
ensure informed choice to undertake labour 
following a previous caesarean section.
Caesarean Section continues to be a 
common mode of delivery; accounting for 
almost half of the 209 infants 45% over 
the three year period 2016-2018. Of these 
deliveries, 3% were planned Caesarean 
Sections. Over the three year period a 
slightly higher proportion of women had a 
Caesarean Section after the onset the labour.
•  49% of mothers had a Caesarean Section 
pre-labour 
•  51% of mothers had a Caesarean section 
after the onset of labour
Over the three year period, 34% of deliveries 
required instrumental assistance, and of 
these women 26% required both forceps and 
ventouse to deliver. The median interval from 
time of decision to delivery for instrumental 
delivery was 16 minutes. 
The umbilical cord pH measures the 
degree of acidosis caused by hypoxia. The 
normal value is 7.25. A value less than 7.0 is 
indicative of severe hypoxia, and readings 
between 7.0 and 7.25 are in keeping with 
moderate hypoxia. In 2018 Cord pH was 
recorded for 63 of the 69 TH infants, and 
59% of these infants had a Cord pH <7.0. The 
composite data 2016-2018 found that 63% 
infants had a Cord pH <7.0. It is important 
that the umbilical cord blood gases are 
measured in all TH cases.
In 2018, 60% of infants required tracheal 
intubation during resuscitation. One in three 
infants needed chest compressions and 
16% were administered Adrenaline. These 
findings are consistent across the three year 
period, demonstrating that two-thirds of 
TH infants require intensive resuscitation at 
birth. It further illustrates the necessity that 
all maternity units have a fully trained team 
capable of performing neonatal resuscitation 
on a 24 hours basis.
In 2018, 81% of TH infants achieved the 
target temperature range 33°C -34°C within 
six hours of birth. The composite data 2016-
2018 shows that 82% TH infants achieved 
the optimum temperature range within six 
hours of birth. It is important to note that 
the process of therapeutic hypothermia 
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had begun in all but 1% of the cases. The 
timing of the decision about when to start 
therapeutic hypothermia is an important 
factor in determining whether the target is 
reached within six hours. 
In 2018, the severity of encephalopathy 
among the affected infants was severe 27%, 
moderate 57%, and mild 16%.The composite 
data 2016-2018 was severe 29%, moderate 
58% and mild 14%. Over three-quarters of 
the infants are moderately/severely impaired 
in the early hours and days after birth. The 
findings confirm that this is a critically ill 
cohort of infants.
The Sarnat score is a clinical tool that 
quantifies the neurological status of an 
infant with NE. In keeping with 2016/2017, 
documentation of the infant’s Sarnat Score 
remains sub-optimal in 2018. The level of 
consciousness is undocumented in 19% of 
cases on day 1, 40% of cases on day 2 and 
52% of cases on day 3. The pattern is similar 
for the other components of the Sarnat 
score. For example, the pupil responses are 
undocumented in 41% of cases on day 1, 
69% of cases on day 2, and 70% cases on 
day 3. Daily documentation of the Sarnat 
score during the days of TH is important and 
should be adopted as an essential standard 
of care in all units providing TH.
In 2018, 15% of infants had a clinical 
seizure on day 1 and 13% of infants had 
a clinical seizure on day 2. No infant had 
a clinical seizure documented on day 3. 
Electrographic seizures were recorded on 
aEEG and were reported for 20% of infants 
on day 1, 15% on day 2 and 6% on day 3. 
The composite 2016/17/18 data illustrate 
that 24% of infants had a seizure on day 1, 
20% infants on day 2, and 13% on day 3. The 
electrographic seizure rate was 31% on day 
1, 20% on day 2 and 9% on day 3. The higher 
electrographic seizure identified on aEEG 
rate compared to the clinical seizure rate 
confirms that many seizures are sub-clinical. 
These findings underscore the importance of 
aEEG/EEG monitoring of all TH infants. 
In 2018, MRI findings were available for 85% 
of TH infants of which 74% were normal. The 
proportion of cases which were abnormal 
were slightly lower in 2018 (26%) compared 
to the findings from the three years of data 
from 2016-2018 where 32% of cases were 
abnormal. 
In 2018, the placenta was retained for 
histological analysis in three-quarters of TH 
cases (77%). Placentas of infants with NE 
that underwent TH, showed over a 6-fold 
increase in fetal vascular malperfusion (29%) 
and a similar increase in maternal vascular 
malperfusion (17%) compared to the general 
population (5% and 3% respectively). 
Analysis of the data provides information 
on how the management of TH cases could 
be improved. It identifies risk factors for 
the development of NE. As the collection 
of TH cases gets larger, it may be possible 
to quantify these risks in a manner that 
can influence clinical practice. The process 
of reducing the incidence of NE requiring 
TH treatment will be an aggregation of 
marginal gains. While sentinel events 
may be difficult to predict, improved 
risk assessment (maternal disease) and 
better risk identification and stratification 
(IUGR, male fetus, primigravida woman, 
induction of labour) will identify at risk 
babies including sentinel event risks. Clear, 
agreed national care pathways and the 
standardisation of multidisciplinary training 
should achieve improvements and lead to 
increasing positive outcomes for infants 
including a reduction in NE. Furthermore, 
the findings will enable us to contribute to 
the international consensus and expertise in 




•  During 2016-2018, 209 NE infants were treated with TH, indicating that  one 
in 900 infants born in Ireland are treated with TH. Consistent data collection, 
analysis and action is needed to reduce the incidence of NE. 
•  NE is a significant cause of enduring morbidity and is the largest cause of 
mortality in normally formed term infants. The total survival rate for infants in 
the TH cohort for the time period 2016-2018 was 89% with 24 infant deaths. 
•  The antenatal detection of intrauterine growth restriction is important. During 
the 3-year period 18% of infants who underwent TH were small for dates (<10th 
centile) for their gestation at birth but this was rarely (4%) detected at birth. 
•  The standardisation of the interpretation of CTG and subsequent clinical 
response should be encouraged. 
•  The diagnosis and appropriate management of maternal pyrexia, shoulder 
dystocia and uterine rupture are recurrent challenges. 
•  There should be a heightened awareness of antecedent obstetric risk factors 
including primiagravida mothers, endocrine disorders, assisted reproduction 
and previous caesarean section. 
•  Over the three year period, 82% of infants achieved optimum core temperature 
range within six hours of birth. The cooling candidacy checklist is an effective, 
reliable tool in the identification of infants requiring TH treatment with 
moderate and severe encephalopathy. Through the maintenance of an annual 
register evolving evidence of therapeutic creep will be captured. 
•  In total 40% of TH infants were born in a peripheral hospital and required 
transfer to one of the four tertiary centres that administer TH. The National 
Neonatal Transport Programme (NNTP) plays an important role in the retrieval 
of NE infants from peripheral hospitals. 
•  Placental examination was undertaken in 54% of NE cases. The commonest 
abnormalities were chorioamnionitis (30%) and maternal vascular malperfusion 
(MVM) (27%). In many cases the placental findings provides an explanation of 
the cause of NE. 
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1.  Enhanced awareness of the risk factors for 
NE (first time mothers, induced mothers, 
IUGR etc.) through standardisation of care 
pathways and multidisciplinary training 
among front line staff is needed.
  The findings from this report provide 
additional information to help improve the 
understanding of the risk factors associated 
with NE. Improving knowledge through the 
introduction of training programmes and 
tools for front line staff to help develop 
strategies for minimising delays and 
initiating interventions if appropriate.
2.  Appropriate counselling for informed 
consent and standardised care pathways 
for labour management of mothers with 
previous caesarean sections should be 
introduced at a national level.
  Caesarean section has become an 
increasingly common method of delivery, 
with one in three women being delivered 
by caesarean in the Republic of Ireland 
per annum. When women, who have had 
a previous caesarean section delivery, are 
being counselled either for VBAC or repeat 
elective caesarean section they must be 
provided with comprehensive standardised 
information about the associated risks 
and adverse outcomes and document the 
discussion.
3.  A National standardised assessment for 
the diagnosis of fetal growth restriction 
(FGR) is warranted and should include 
multidisciplinary training.
  International evidence illustrates that 
suboptimal fetal growth is linked to both 
short and long-term adverse outcomes. 
Findings from this report illustrates there 
was some evidence of poor fetal growth 
with almost 20% of the infants born below 
the 10th centile. The establishment of a 
multidisciplinary working group to address 
a national standardised approach for the 
detection of FGR is warranted. 
4.  Multidisciplinary skills and drills training 
to deal with obstetric sentinel events are 
required. 
  Sentinel events; such as uterine rupture, 
placental abruption and shoulder dystocia, 
are acute events that are associated with 
NE. Training, with 1-2 yearly re-certifications, 
on the management of major obstetric 
situations is required for all levels.
5.  Front line staff responsible for CTG 
interpretation must undertake annual 
training.
  Fetal monitoring, including continuous 
cardiotocography (CTG), requires expert 
knowledge and interpretation and should 
be undertaken by skilled front line staff. 
Anonymised CTG reports should be 
submitted to the NPEC as part of this audit 
to facilitate interpretation from an expert 
panel of Midwives and Obstetricians. 
6.  An Umbilical cord pH measurement and the 
retention of the placenta for histopathology 
assessment are required in each case where 
an infant requires resuscitation and is 
treated with TH.
  The findings from this report have indicated 
that a cord pH measurement was not taken 
in 13% of cases and placenta histology was 
not undertaken in 25% of cases where an 
infant is treated with TH.
7.  The Neonatal Resuscitation Programme 
(NRP) needs to be a requirement with 2 
yearly re-certification for all staff working in 
birthing areas. This should be implemented 
with appropriately trained personnel.
  It is important that trained personal attend 
these births. A national NRP Coordinator is 
advocated in order to manage and provide 
governance for the NRP programme within 
the 19 maternity units.
8.  All therapeutic hypothermia infants require 
daily Sarnat grading assessment as a 
standard of care.
  The Sarnat grading scale is an internationally 
recognised classification assessment 
tool for Neonatal Encephalopathy in the 
newborn infant. Regular assessment is 
prudent to determine the progression of 
encephalopathy, exclude other causes of 
encephalopathy and provide prognostic 
information to families. This subsequent 
2018 TH report mirrors the findings of 
the 2016/2017 report in which there is 
incomplete data for Sarnat scoring on TH 




The NCPPN in collaboration with NPEC and 
NWIHP presents its successive report on 
Neonatal TH in the Republic of Ireland for 
2018. We now have three years, 2016-2018, 
cumulative comprehensive data to determine 
the current status and outcomes for infants 
who underwent TH during this time frame.
This report presents the 2018 data alongside 
the 2016/2017 data for comparative analysis. 
By laying out the report in this format it is 
anticipated that patterns and trends will begin 
to emerge.
Going forward the implementation of the 
electronic register in 2020 will serve as a 
much needed platform to inform clinicians 
of identified maternal and infant trends 
alongside clinical risk factors which will 
assist in the development of maternal risk 
profiles leading to a change in their antenatal 
and delivery management. Furthermore an 
e-register will facilitate benchmarking of TH 
in Ireland against international standards and 
thus ensure continuous quality improvement. 
TH is an evolving treatment and by 
maintaining a constant record of the data 
on the e-register, the value of the adjunctive 
therapies during TH treatment can be 









Assessment for Therapeutic Hypothermia






Discharge diagnosis and Death
Placenta findings
MRI findings
9.  aEEG training required to accurately 
determine neurophysiological status of 
infant undergoing TH.
  Seizures are a common feature of neonatal 
encephalopathy. aEEG monitoring is 
important in order to assess the severity 
of encephalopathy. Training is required for 
optimal interpretation of the aEEG findings. 
An aEEG elearning programme is in the final 
stage of development in collaboration with 
the Royal College of Physicians (RCPI). 
10.  Brain MRIs should be performed between 
days 5-10 for optimal imaging results.
  MRI is the modality of choice for assessment 
of brain injury severity in cases of NE. 
Timing of the MRI scan is important in the 
identification of the initial diffusion changes. 
If there is a delay in undertaking the scan 
the early findings can be missed because of 
pseudo normalisation.
11.  Neurodevelopmental follow-up.
  All TH infants should be followed up to 
assess their motor, cognitive and speech and 
language development. Future reports will 
provide two year follow-up data on Bayley 
assessment outcomes.
12.  Continuous yearly reviews are needed for 
TH cases using the electronic register to 
enhance knowledge and learning.
  The development of the national e-register 
in 2020 will facilitate benchmarking against 
international registries and databases. 
The register will enable us to evaluate 
new adjunctive therapies. Furthermore, 
the maintaining of a yearly register will 
contribute to a body of evidence which 
will have the ability to develop risk profiles, 
standardise clinical practice, inform public 
health interventions and service planning. 
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Purpose of this report
The primary aim of this report is to present an overview and national statistics on 
Neonatal Therapeutic Hypothermia in the Republic of Ireland for the year 2018. 
Therapeutic Hypothermia (TH) is administered in four centres only (National Maternity 
Hospital, Rotunda, Coombe Women and Infants University Hospital and Cork University 
Maternity Hospital). All babies born in other local and regional hospitals needing this 
treatment are transferred to one of these four centres. 
The audit will examine the clinical details around each case of Neonatal Therapeutic 
Hypothermia. This will include the mothers’ antenatal details, labour, delivery, 
resuscitation, neurological assessment, treatment of seizures, the supportive clinical 
care the examination of the placenta and post mortem, if applicable.
Data Collection
Retrospective reviews of inpatient medical records have been used as a gold standard 
approach when assessing multiple outcomes and rates of adverse events. Therefore, 
for the purposes of the National Neonatal Therapeutic Hypothermia Audit, medical 
records were considered the primary source of information. Data were collected on 
site in the 19 maternity units/hospitals and neonatal intensive care units or special care 
baby units (NICU/SCBU) in the Republic of Ireland. The NCPPN and NPEC collected 
data on all cases of neonatal therapeutic hypothermia in 2018 by taking an active case 
ascertainment approach. 
Processing of the data
Data on all infants who received therapeutic hypothermia were collected on site in 
the 19 maternity units/hospitals. The data were submitted by paper to the NPEC and 
were processed in a pseudonymised format. No hospital identifiers were included in 
the dataset, which means these data cannot be attributed to a specific hospital or to a 
specific individual. 
Missing data 
To ensure accuracy of information, missing or incomplete data were sought from the 
respective maternity hospitals/units by the Therapeutic Hypothermia Co-Ordinator. For 
analysis purposes, cases with missing data were excluded from calculations. However, 
the extent of missing data is reported in the results section.
Comparison to National Statistics
Comparisons are made with the most recent publications available, including the 
Central Statistics Office’s Vital Statistics Fourth Quarter and Yearly Summary report as 
well as from the Healthcare Pricing Office.
Methods 
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Definitions & Terminology 
Neonatal Encephalopathy (NE) is a clinical condition in the term infant defined by abnormal 
neurological behaviour, with the onset occurring at or shortly after birth. 
NE is manifested by an abnormal level of consciousness, with or without the presence of seizures 
and is often accompanied by difficulty initiating and maintaining respirations, depressed tone and 
depressed reflexes, poor suck and swallow. 
NE incidence is estimated as 3.0 per 1000 live births and for HIE is 1.5.1 NE is graded as mild, 
moderate or severe using the Sarnat grading system. 
A subgroup of infants with NE have been exposed to a hypoxic-ischaemic insult in-utero and 
therefore they are assigned a diagnosis of Hypoxic-Ischaemic Encephalopathy (HIE). In a proportion 
of these cases, a sentinel event is identified i.e. placental abruption, uterine rupture etc. 
TH has been found to be protective in those infants presenting with moderate or severe NE by 
inhibiting various events in this cascade of HIE injury. Major randomized clinical trials3-5 involving 
induced neonatal hypothermia have demonstrated a reduction in death and disability.6-8 These trials 
have shown improved outcomes for babies with NE if they are cooled within six hours of birth to a 
targeted core body temperature of between 33°C to 34°C for a duration of 72 hours. Rewarming to 
normothermic temperature occurs over a 6-12 hour period. TH is considered to be the standard of 
care for infants with moderate-to-severe NE who meet inclusion criteria. 
  Suggested criteria for an intrapartum 
hypoxic-ischaemic insult2 include: 
(i)  Evidence of metabolic acidosis in fetal 
umbilical cord arterial blood obtained 
at delivery (pH <7 and base deficit ≥ 12 
mmol/L).
(ii)  Early onset of severe or moderate NE in 
infants ≥ 34/40.
(iii)  A sentinel hypoxic event occuring 
immediately before or during labour e.g. 
uterine rupture, placental abruption, cord 
prolapse etc.
(iv)  A sudden and sustained fetal bradycardia 
or the absence of fetal heart rate 
variability in the presence of persistent 
late or persistent variable decelerations on 
cardiotocography, usually after a hypoxic 
sentinel event when the pattern was 
previously normal.
(v)  Apgar scores of 0-3 beyond 5 minutes.
(vi)  Onset of multisystem involvement within 
72 hours of birth.
(vii)  Early imaging study showing evidence of 
acute non-focal cerebral abnormality.
(viii)  Exclusion of other identifiable aetiologies 
e.g. trauma, coagulation disorders, 
infection or genetic disorders. 
 The inclusion criteria for TH are:
•  ≥ 36 weeks completed gestation with a 
weight ≥ 1800grams.
•  Acidosis (pH<7.0) present in the umbilical 
cord, or any blood sample taken within 60 
minutes of birth.
•  Base deficit ≥ -16.0 mmol/L in umbilical cord 
or any blood sample taken within 60 minutes 
of birth.
•  History of acute perinatal event (such as 
but not limited to cord prolapse, placental 
abruption or uterine rupture).
•  Apgar score ≤ 5 at 10 minutes or at least 10 
minutes of positive-pressure ventilation.  
•  Evidence of moderate-to-severe 
encephalopathy, demonstrated by the 
presence of seizures OR at least one sign in 
three or more of the six categories shown In 
the Modified Sarnat Table (see Table 38).
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Main Findings




The age of mothers whose infants underwent therapeutic hypothermia was known for 68 of 
the 69 mothers in 2018. The mothers whose infants underwent therapeutic hypothermia ranged 
in age from teenage years (the youngest being 17 years of age) through to early-forties (the 
eldest being 42 years of age). Their age distribution broadly reflected that of the population of 
mothers who gave birth in Ireland in 2016 (Table 1). There was a higher proportion of mothers 
aged 24 or younger years (14.7%) whose babies were cooled in 2018, than all mothers who gave 
birth in 2016 (9.6%)9. Over half of the population (52.3%)9 who gave birth in 2016 were aged 25-
34 years, whereas a slightly lower proportion of mothers whose infants underwent therapeutic 
hypothermia between 2016-2018 were in this age group (50.9%). 
Table 1: Age distribution of mothers whose infants underwent therapeutic hypothermia in 2016-
2018 versus all births in 2016
Age group
TH cases  
N=63  
2016
TH cases  
N=77  
2017
TH cases  
N=68  
2018*
TH cases  
N=208  
2016-2018
All births9  
N=64,133  
2016 (%)
<20yrs 1(1.6) 0(0.0) 3(4.4) 4(1.9) 1.7
20-24yrs 8(12.7) 8(10.4) 7(10.3) 23(11.1) 7.9
25-29yrs 9(14.3) 15(19.5) 10(14.7) 34(16.3) 17.3
30-34yrs 23(36.5) 24(31.2) 25(36.8) 72(34.6) 35.0
35-39yrs 18(28.6) 25(32.5) 18(26.5) 61(29.4) 28.6
>40yrs 4(6.3) 5(6.5) 5(7.4) 14(6.7) 6.7
Note: Values are shown as N(%) unless otherwise stated. *Age unknown for one mother. 
Ethnicity
Assessment of risk associated with ethnic group is impeded by the absence of national data 
on ethnicity for the pregnant population in Ireland. The majority of mothers whose infants 
underwent therapeutic hypothermia in 2018 were of white Irish ethnicity (72.1%, n=49 of 68; 
missing data for one mother) (Table 2). This is similar to the proportion of white Irish women 
in the female population aged 15-49 years, enumerated by the National Census 2016. While the 
numbers involved were small, Irish Traveller, Asian and Black ethnicities were overrepresented in 
the mothers whose infants underwent therapeutic hypothermia in 2018 (8.8%) compared to 5.3% 
of the female 15-49-year-old population from the National Census in 2016.
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Table 2: Ethnicity of mothers whose infants underwent therapeutic hypothermia in 2016-2018 
versus 15-49 year-old female population, 2016
Ethnicity
TH cases  
N=63  
2016
TH cases  
N=75  
2017*
TH cases  
N=68  
2018**






White Irish 53(84.1) 52(69.3) 49(72.1) 154(74.8) 79.2
Irish Traveller 0(0.0) 2(2.7) 1(1.5) 3(1.5) 0.7
Other white background 6(9.5) 14(18.7) 12(17.6) 32(15.5) 13.7
Asian/Asian Irish 4(6.3) 3(4.0) 2(2.9) 9(4.4) 2.9
Black/Black Irish 0(0.0) 4(5.3) 3(4.4) 7(3.4) 1.7
Other/mixed 0(0.0) 0(0.0) 1(1.5) 1(0.4) 1.9
Note: Values are shown as N(%) unless otherwise stated. *Ethnicity unknown for two mothers.  
**Ethnicity unknown for one mother. ***Population data from the National Census 2016.
Occupation
Table 3 provides a high-level overview of the data provided on mother’s occupation, alongside 
data available for the most comparable occupation categories for mothers of all births in Ireland9 
and for the 15-44 year-old female population from the National Census 2016. Employment status 
was specified for 95.7% (n=66 of 69) of the mothers for whom data were recorded in 2018 (Table 
3). It can be seen that unemployed status was recorded for 16.7% of the mothers whose infants 
underwent therapeutic hypothermia compared to 4.5% of all mothers and 8.2% of the female 
population aged 15-44 years. The proportion of mothers engaged in home duties whose infants 
underwent therapeutic hypothermia (4.5%) was lower than the percentage of all women engaged in 
home duties who gave birth (20.5%) in 2016 but was similar to the proportion of females aged 15-49 
years in the Irish population (10.4%).
Table 3: Occupation at booking of mothers whose infants underwent therapeutic hypothermia in 
2016-2018 versus all births in 2016 and 15-44 year-old female population in 2016
Occupation
TH cases  
N=53  
2016*
TH cases  
N=65  
2017**
TH cases  
N=66  
2018***









Employed 43(81.1) 48(73.8) 49(74.2) 140(76.1) 73.1 57.8
Unemployed 1(1.9) 10(13.0) 11(16.7) 22(12.0) 4.5 8.2
Home duties 5(1.9) 4(5.2) 3(4.5) 12(6.5) 20.5 10.4
Student 4(7.5) 3(3.9) 3(4.5) 10(5.4) n/a 21.1
Others not in 
labour force
0(0.0) 0(0.0) 0(0.0) 0(0.0) n/a 2.5
Note: *Data not known on employment for 10 mothers **Data not known on employment for 12 mothers  
***Data not known on employment for 2 mothers. **Population data from Census 2016.
Body Mass Index
Body Mass Index (BMI) was available for 62 of the 69 women whose infants underwent therapeutic 
hypothermia in 2018 (Table 4). The pattern of BMI in the mothers was similar to that from the general 
population who participated in the 2017 Healthy Ireland Survey10. The BMI of 32.3% of these mothers 
was in the obese range (>30.0kgm-2), which is higher than those from the general population.
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Table 4: Body mass index of mothers whose infants underwent therapeutic hypothermia in 2016-
2018 versus all participants in the Healthy Ireland Survey in 2017
BMI Category (kg/m2)
TH cases  
N=62  
2016*
TH cases  
N=72  
2017**
TH cases  
N=62  
2018**




Survey 2017  
(%)10
Underweight (<18.5) 1(1.6) 2(2.8) 0(0.0) 3(1.5) 2
Healthy (18.5-24.9) 22(35.5) 33(45.8) 23(37.1) 78(39.8) 36
Overweight (25.0-29.9) 22(35.5) 20(27.8) 19(30.6) 61(31.1) 39
Obese (>30.0) 17(27.4) 17(23.6) 20(32.3) 51(26.0) 23
Note: Values are shown as N(%) unless otherwise stated. *BMI value missing for six mothers.  
**BMI value missing for five mothers. ***BMI value missing for seven mothers.
Smoking and substance abuse
Smoking status of the mothers at their time of booking was recorded for 68 (98.6%) of the 69 women. 
Of these, 10 (14.7%) were smokers at the time of booking; this is slightly lower than the prevalence 
of all female smokers in the Irish population in 2018 (17%)11. Information on smoking was available for 
seven of the ten smokers (70.0%). Five women were smoking between 1 and 9 cigarettes per day 
(n=5 of 7, 71.4%) and two were smoking 10 or more cigarettes per day (n=2 of 7, 28.6%). Of the seven 
women who were smoking at booking, two (28.6%) stopped smoking during pregnancy. There were no 
pregnancies with a documented history of alcohol abuse, but one woman had a documented history of 
drug abuse prior to pregnancy.
Previous pregnancy 
In terms of parity of women who delivered infants requiring therapeutic hypothermia in 2018, there was 
an overrepresentation of women who had not previously delivered (56.5%) compared to the general 
population of women who gave birth in 2016 (38.2%; Table 5).
Table 5: Distribution of parity, 2016-2018
Parity
TH cases  
N=63  
2016
TH cases  
N=77  
2017
TH cases  
N=69  
2018
TH cases  
N=209  
2016-2018
All births*  
2016  
(%)
Nulliparous 42(66.7) 42(54.5) 39(56.5) 123(58.9) 38.2
Para 1 13(20.6) 21(27.3) 19(27.5) 53(25.4) 34.9
Para 2 5(7.9) 8(10.4) 7(10.1) 20(9.6) 17.9
Para 3+ 3(4.8) 6(7.8) 4(5.8) 13(6.2) 9.0
Note: Values are shown as N(%) unless otherwise stated. *Population data from the Healthcare Pricing Office9
Table 6 specifies the gravidity/parity of the 69 women whose infants underwent neonatal therapeutic 
hypothermia in 2018. Nearly half (n=39, 56.5%) had never been pregnant before (gravida = 0). Of the 
30 women who had been pregnant (gravida > 0), 96.7% (n=29) had pregnancies exceeding 24 weeks 
or 500g birthweight (gravida = parity, indicated by green shading). One of the women had experienced 
at least two pregnancies exceeding 24 weeks or 500g birthweight and one pregnancy less than 24 
weeks gestation and under 500g birthweight (gravida > parity > 0, indicated by yellow shading).
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0 1 2 3 4 5 Total
0 39 39
1 0 19 19
2 0 0 6 6
3 0 0 1 2 3
4 0 0 0 0 0 0
5 0 0 0 0 0 2 2
Total 39 19 7 2 0 2 69
Note: We refer to gravidity and parity prior to the pregnancy associated with neonatal therapeutic hypothermia. 
Green represents women with previous pregnancies that were all ≥24 weeks or ≥500g; yellow represents women 
who had experienced pregnancy ≥24 weeks or ≥500g and also pregnancy <24 weeks and <500g; and orange 
represents women whose previous pregnancies were always <24 weeks gestation and <500g birthweight.
Of the 30 women who had a previous pregnancy, 30.0% (n=9) were reported to have had a previous 
pregnancy-related problem (undocumented for one). Caesarean section delivery was the most 
common previous pregnancy-related problem, with twenty percent of mothers (n=6, 20.0%) having 
a previous caesarean section delivery (Table 7). Placental abruption and an infant requiring intensive 
care were both the second most common pregnancy-related problem in mothers who had a previous 
pregnancy (n=2; 6.7%). None of the mothers had an infant with Hypoxic Ischaemic Encephalopathy 
(HIE) in a previous pregnancy.
Table 7: Previous pregnancy-related problems in mothers whose infants underwent therapeutic 
hypothermia in 2018
TH cases  
N=28  
2016
TH cases  
N=47  
2017
TH cases  
N=30  
2018
TH cases  
N=105  
2016-2018
Previous caesarean delivery 6(21.4) 8(17.0) 6(20.0) 20(19.0)
Three or more miscarriages 1(3.6) 4(8.5) 1(3.3) 6(5.7)
Infant requiring intensive care 0(0.0) 3(6.4) 2(6.7) 5(4.8)
Pre-term birth or mid-trimester loss 2(7.1) 1(2.1) 0(0.0) 3(2.9)
Neonatal death 1(3.6) 0(0.0) 1(3.3) 2(1.9)
Pre-eclampsia 2(7.1) 0(0.0) 0(0.0) 2(1.9)
Stillbirth 1(3.6) 1(3.6) 1(3.3) 3(2.9)
Other 0(0.0) 1(2.1) 2(6.7) 3(2.9)
Infant with congenital anomaly 0(0.0) 0(0.0) (0.0) 0(0.0)
Placenta abruption 0(0.0) 1(2.1) 2(6.7) 3(2.9)
Placenta praevia 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Post-partum haemorrhage requiring transfusion 0(0.0) 0(0.0) 1(3.3) 1(0.9)
Previous infant with HIE 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Note: Percentage relates to total number of mothers who had a previous pregnancy (n=105). Categories are not 
mutually exclusive. Values are shown as N(%) unless otherwise stated.
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Pre-existing medical problems
One in four of the women, whose infants underwent therapeutic hypothermia in 2018, had a pre-
existing medical problem (n=7, 23.3%). Fifteen of the 69 women were taking prescribed medication 
during the pregnancy (21.7%). Four mothers had a documented family history of conditions which 
can affect newborn infants (5.8%, n=4). The most common type of pre-existing medical problems 
were endocrine disorders, with 8.7% of mothers (n=6) suffering from conditions of this type (Table 8). 
Psychiatric disorders also had the highest percentage of occurrence (8.7%, n=6). 
Table 8: Pre-existing medical problems in mothers whose infants underwent therapeutic 
hypothermia in 2018
TH cases  
N=63  
2016
TH cases  
N=77  
2017
TH cases  
N=69  
2018
TH cases  
N=209  
2016-2018
Endocrine disorder 7(11.1) 3(3.9) 6(8.7) 16(7.7)
Psychiatric disorder 4(6.3) 3(3.9) 6(8.7) 13(6.2)
Hypertension 3(4.8) 1(1.3) 0(0.0) 4(1.9)
Haematological disorder 1(1.6) 2(2.6) 0(0.0) 3(1.4)
Diabetes 1(1.6) 1(1.3) 1(1.4) 3(1.4)
Cardiac disease 0(0.0) 1(1.3) 1(1.4) 2(0.9)
Inflammatory disorder 0(0.0) 1(1.3) 0(0.0) 1(0.5)
Renal disease 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Epilepsy 0(0.0) (0.0) 2(2.9) 2(0.9)
Other 7(11.1) 18(23.4) 9(13.0) 34(16.3)
Note: Percentage relates to total number of mothers, categories are not mutually exclusive. 
Antenatal care 
Currently in Ireland, there is no national data on the number of births as a result of fertility 
treatment. Information was available for 68 of the 69 (98.6%) whose infants underwent therapeutic 
hypothermia in 2018. In six of these cases (8.8%), the pregnancy was reported to be the result of 
fertility treatment. In vitro fertilisation was the method of fertility treatment specified for five of the 
six pregnancies and all bar one of these women were aged between 30-34 years (83.3%; n=5 of 6). In 
terms of parity the majority of women were nulliparous (83.3%; n=5 of 6).
During this pregnancy, the majority of the 69 women intended on delivering in an obstetric unit 
(91.3%; n=63) with obstetric-led care (89.9%; n=62). One in five women had an antenatal ultrasound 
scan before 12 weeks gestation (20.3%; n=14) and over half of the women had a scan between 12 
and 15 weeks gestation (58.0%; n=40). Gestation at booking was unknown for five women and two 
women were unbooked (Table 9). Estimated date of delivery (EDD) was documented for 67 of the 69 
women. EDD was calculated using ultrasound scan in the majority of cases (97.0%; 65 of 67). 
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Table 9: Timing of antenatal hospital booking appointment for mothers whose infants underwent 
therapeutic hypothermia in 2016-2018
TH cases  
N=63  
2016
TH cases  
N=77  
2017
TH cases  
N=69  
2018
TH cases  
N=209  
2016-2018
Less than 12 weeks 16(25.4) 22(28.6) 14(20.3) 52(24.9)
12-15 weeks 40(63.5) 40(51.9) 40(58.0) 120(57.4)
15-19 weeks 5(7.9) 9(11.7) 7(10.1) 21(10.0)
20 weeks of later 2(3.2) 2(2.6) 1(1.6) 5(2.4)
Unknown 0(0.0) 4(5.2) 5(7.2) 9(4.3)
Unbooked 0(0.0) 0(0.0) 2(2.9) 2(0.9)
Note: Values are shown as N(%) unless otherwise stated. 
Gestation at last antenatal hospital visit
Information on the last antenatal visit was available for 67 of the 69 women whose infants underwent 
therapeutic hypothermia in 2018 (97.1%). These 67 women last attended the hospital clinic between 33 
and 42 weeks. Almost 90% attended at 36 weeks or later (89.6%, n=60) with 17.9% (n=12) last attending 
the hospital before the last routine antenatal clinic visit at 37 weeks gestation (Figure 1). Of the 69 
women, one was transferred from another maternity unit with the fetus in utero at 37 gestational weeks.
Figure 1: Weeks gestation at last antenatal visit, 2018
Concern documented during pregnancy
Of the 69 cases, there were concerns documented during the pregnancy for 26 (37.7%) of the mothers 
whose infants underwent therapeutic hypothermia in 2018. One in three of these women had two 
or more concerns documented (30.8%; n=8 of 26). The most common concern documented was 
gestational diabetes mellitus with 10.1% (n=7) of mothers developing this condition during pregnancy. 
This was followed by hypertensive disorders which had the second highest percentage of occurrence 
(7.2%, n=5). Polyhydramnios and infants recorded as large for gestational age were also the third most 
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Labour 
Information on the onset of labour was available for all 69 women whose infants underwent therapeutic 
hypothermia (100%). Almost half of the women laboured spontaneously (47.8%; n=33), over a third of 
women were induced (33.3%; n=23) and 18.8% of women were never in labour (Table 10). Almost half of the 
women who laboured spontaneously had their labour accelerated (45.5%; n=15 of 33), either by artificial 
rupture of membranes (ARM; 53.3%, n=8 of 15) or oxytocin (26.7%; n=4 of 15). Three women (20.0%; n=3 of 
15) had their labour accelerated with both (Table 11).
















Spontaneous 102(48.8) 19(45.2) 22(52.4) 19(48.7) 10(47.6) 18(51.4) 14(46.7)
Induction 71(34.0) 22(52.4) 13(31.0) 12(30.8) 6(28.6) 7(20.0) 11(36.7)
Never in labour 36(17.2) 1(2.4) 7(16.7) 8(20.5) 5(23.8) 10(28.6) 5(16.7)
Note: Values are shown as N(%) unless otherwise stated.
















Artificial rupture of  
membranes
25(55.6) 3(27.3) 6(54.5 4(44.4) 3(100) 5(100) 4(66.7)
Oxytocin 17(37.8) 8(72.7) 5(45.5) 2(22.2) 0(0.0) 0(0.0) 2(33.3)
Both 3(6.6) 0(0.0) 0(0.0) 3(33.3) 0(0.0) 0(0.0) 0(0)
Note: Values are shown as N(%) unless otherwise stated.
As outlined in Table 12, liquor was clear in 27 of the 59 documented cases (45.8%). Two of every five 
women had meconium-stained liquor (40.7%; n=24 of 59). The grade of meconium was specified for 22 of 
the 24 cases (91.7%), with 31.8% of women having Grade 1 (n=7), 50.0% of women having Grade 2 (n=11) 
and the remaining four women having Grade 3 (18.2%).
















Clear 95(45.5) 22(52.4) 19(45.2) 16(41.0) 11(52.4) 16(45.7) 11(36.7)
Meconium 55(26.3) 11(26.2) 10(23.8) 14(35.9) 2(9.5) 8(22.9) 10(33.3)
Other 20(9.6) 5(11.9) 5(11.9) 4(10.3) 0(0.0) 2(5.7) 4(13.3)
Missing/Non-applicable 39(18.7) 4(9.5) 8(19.0) 5(12.8) 8(38.1) 9(25.7) 5(16.7)
Note: Values are shown as N(%) unless otherwise stated. 
There was a documented reason for induction for 19 of the 23 women whose onset of labour was induced. 
As indicated in Table 13, the common reasons to induce labour were associated with post maturity 
(31.6%; n=6 of 19), oligohydramnios (15.8%; n=3 of 19), hypertensive disorders (10.5%; n=2 of 19), large 
for gestational age (10.5%; n=2 of 19) and prolonged spontaneous rupture of membranes (10.5%; n=2 of 
19). Under the “Other” category a range of indications were captured including; suspected IUGR, raised 
dopplers, polyhydramnios, twins, gestational diabetes mellitus and social reasons. 
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Table 13: Reason for induction of mothers whose infants underwent therapeutic hypothermia in 2018






Large for gestational age 2(10.5)
Prolonged SROM 2(10.5)
Other 6(31.6)
Note: Values are shown as N(%) unless otherwise stated. *Categories are not mutually exclusive.
The method of induction was known for all 23 women who were induced (100%). The majority of 
women had their labour induced using multiple methods of induction (56.5%; 13 of 23). As illustrated in 
Table 14, the most common method of induction was the use of oxytocin (60.9%; n=14 of 23), followed 
by prostaglandin gel (52.2%; n=12) and almost half of women had their labour induced with the artificial 
rupture of membranes (43.5%; n=10).

















Oxytocin 43(60.6) 14(63.6) 9(69.2) 7(58.3) 2(33.3) 4(57.1) 7(63.6)
Artificial rupture of 
membranes
37(52.1) 11(50.0) 8(61.5) 6(50.0) 4(66.7) 4(57.1) 4(36.4)
Prostaglandin gel 36(50.7) 12(54.5) 6(46.2) 7(58.3) 4(66.7) 2(28.6) 5(45.5)
Propress 18(25.3) 6(27.3) 6(46.2) 4(33.3) 0(0.0) 1(14.3) 1(9.1)
Other 1(1.4) 1(4.5) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive.
Fetal heart monitoring was undertaken for 61 of the 69 women whose infants underwent therapeutic 
hypothermia (88.4%). The method of fetal heart monitoring was documented for all 61 women (100%). 
As illustrated in Table 15, external continuous fetal heart monitoring was the most common method of 
monitoring used during labour (93.4%; n=57 of 61). Twelve women who underwent external continuous 
fetal heart monitoring also had internal continuous fetal heart monitoring (19.7%; n=12 of 61). A third 
of women who had external intermittent fetal heart monitoring (36.1%; n=22 of 61). Of these women, 
almost half also underwent external continuous fetal heart monitoring during labour (81.8%; n=18 of 22).

















External continuous 143(83.6) 36(90.0) 26(76.5) 36(97.3) 9(69.2) 15(65.2) 21(87.5)
External intermittent 62(36.3) 16(40.0) 10(29.4) 11(29.7) 5(38.5) 9(39.1) 11(45.8)
Internal continuous 16(9.4) 1(2.5) 2(5.9) 6(16.2) 0(0.0) 1(4.3) 6(25.0)
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive.
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Data on cardiotocography (CTG), which could be interpreted, were available for 45 of the 69 cases 
(65.2%). Of these 45, half were interpreted as either pathological (44.4%; n=20) or suspicious 
(6.7%; n=3). A fetal blood sample was taken for 4 of the 69 infants who underwent therapeutic 
hypothermia in 2018 (5.8%). Fetal blood samples were three times more likely to be taken for infants 
with a pathological CTG (15.0%; n=3 of 20) compared to those with a normal CTG (5.6%; n=1 of 18). 
All four infants had a pH greater than 7.0 (Range: 7.2-7.3) from the initial fetal blood sample and the 
median base deficit was 2.1 (Range: 1.3-3.0). 
Delivery
Information on both the day and time of birth was available for all 69 infants who underwent 
therapeutic hypothermia in 2018. The timing of birth was categorised between 08:00 and 19:59 
hours and 20:00 and 07:59hrs. As illustrated in Figure 2, the time of birth varied across the seven 
days of the week. Of all the births, over half were born between 08:00 and 19:59 hours (55.1%; n=38).
Figure 2: Day of week and time of birth (08:00 – 19:59 and 20:00 – 07:59) for infants who 
underwent therapeutic hypothermia in 2018
The type of care received at delivery was known for all mothers whose infants underwent 
therapeutic hypothermia (n=69). The vast majority of the infants (98.6%; n=68) were delivered under 
obstetric-led care, which is the predominant model of care in Ireland. One baby was born before 
arrival at the maternity unit.
Presentation at delivery was known for 92.8% of mothers whose infants underwent therapeutic 
hypothermia (n=64 of 69). The majority of presentations at delivery were vertex presentations (n=61 
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Mode of delivery was known for all mothers (n=69) whose infants underwent therapeutic 
hypothermia in 2018 (Table 16). One in five of infants had a spontaneous vaginal delivery (20.3%, 
n=14), which is considerably lower than the proportion of vaginal deliveries of all births occurring 
in 2016 (52.2%). Almost half of the deliveries were instrumental (47.8%, n=33 of 69). Of the women 
who had an instrumental delivery, five mothers had a combination of a ventouse and a forceps 
delivery. The interval time from decision to the instrumental delivery was known in 29 of the cases. 
The median interval time to delivery was 16 minutes and ranged from four to 45 minutes. Infants 
whose CTG was interpreted as suspicious or pathological were more likely to have an operative 
birth rather than a spontaneous vaginal delivery. 
Caesarean section was the second most common mode of delivery for all 69 of these infants 
(42.0%, n=29), with a slightly higher percentage of caesarean sections happening pre-labour 
(55.2%, n=16 of 29) rather than after the onset of labour (44.8%, n=13 of 29). 
Table 16: Mode of delivery for mothers whose infants underwent therapeutic hypothermia in 2018
TH cases 2018 N=69 All births 20161










Assisted breech 0(0.0) Assisted breech 0.5%
Ventouse** 22(31.9) Ventouse 11.1%
Forceps 11(15.9) Forceps 3.6%
Note: Values are N(%) unless otherwise stated. Categories are not mutually exclusive. +Vaginal births in this 
category include women who had both a Spontaneous Vaginal Cephalic and a Spontaneous Vaginal Breech 
delivery. ++Caesarean section in this category include women who had a pre-labour caesarean section as well as 
women who had a caesarean section after the onset of labour. *Two mothers had a caesarean section following 
failed instrumental deliveries. **Five mothers who had a ventouse delivery, also had a forceps delivery.
The type of caesarean section was documented for all 29 mothers (Table 17). One mother whose 
infant underwent therapeutic hypothermia in 2018 had an elective caesarean section (3.4%; n=1 
of 29) and one had an urgent caesarean section (3.4%; n=1 of 29). Two mothers had a caesarean 
section following a failed instrumental delivery (6.9%; n=2 of 29). Emergency caesarean section 
delivery was the most common type of caesarean section delivery, accounting for 86.2% of cases 
where the infant was delivered by caesarean section (n=25 of 29). Of the women who had an 
Emergency caesarean section delivery, 56.0% (n=14 of 25) were pre-labour and 44.0% (11 of 25) 
occurred after the onset of labour. 
Table 17: Type of caesarean section delivery for mothers whose infants underwent therapeutic 
hypothermia in 2018
TH cases  
N=29  
2016
Elective – planned 1(3.4)
Urgent – maternal or fetal compromise which is not immediately life threatening 1(3.4)
Emergency – immediate threat to life of woman or fetus 25(86.2)
Failed instrumental delivery 2(6.9)
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Other incidences at birth and following delivery
As outlined in Table 18, 13.0% of women whose infants underwent therapeutic hypothermia had a 
prolonged rupture of membranes (n=9). One in twenty women experienced maternal pyrexia during 
labour (n=3).
Table 18: Other incidences at the birth of infants who underwent therapeutic hypothermia in 2016-2018
TH cases  
N=63  
2016
TH cases  
N=77  
2017
TH cases  
N=69  
2018
TH cases  
N=209  
2016-2018
Maternal pyrexia in labour 14(22.2) 12(15.6) 3(4.3) 29(13.9)
Shoulder dystocia 10(15.9) 8(10.4) 9(13.0) 27(12.9)
Prolonged rupture of membranes 7(11.1) 7(9.1) 9(13.0) 23(11.0)
Subgaleal haematoma 1(1.6) 2(2.6) 0(0.0) 3(1.4)
Spontaneous premature labour 0(0.0) 1(1.3) 0(0.0) 1(0.5)
Birth trauma 1(1.6) 0(0.0) 0(0.0) 1(0.5)
Other 7(11.1) 13(16.9) 2(2.9) 22(10.5)
Note: Values are shown as N (%) unless otherwise stated. Categories are not mutually exclusive.
Uterine rupture
Over the one year period, there were three reported cases of uterine rupture which equates to a rate of 
43.5 per 1,000 within this cohort. This rate is significantly higher than the incidence of uterine rupture 
in the Irish general population which has consistently been reported at 0.14 per 1,000 maternities 
since 201112. All the women who experienced uterine rupture were parous. Two of the three women 
were reported to have had a caesarean section in a previous pregnancy. One woman had an elective 
caesarean section in this pregnancy, while the remaining two women had a caesarean section after the 
onset of labour. The birth weight of these infants ranged from 3480 grams to 4120 grams.
Shoulder dystocia infants
During delivery of the 69 infants, there were nine reported incidents of shoulder dystocia (13.0%). This 
rate is 9 times higher than that reported for all deliveries (1.4%) in high-income countries13. Of nine 
reported incidents of shoulder dystocia, two-thirds of the women were nulliparous (66.7%; n=6 of 9). 
Five of the nine women (55.6%) had an induction of labour (Table 19) and three of the four women who 
laboured spontaneously had their labour accelerated. 
Eight of the nine women had an instrumental delivery (88.9%). The median interval time between 
decision and delivery was 17 minutes, ranging from 9 to 26 minutes. Of the nine women who had an 
instrumental delivery, two-thirds of the women (66.7%; n=6 of 9) had their birth assisted with ventouse, 
with one woman (11.1%; n=1 of 9) having a combination of ventouse and forceps. 
The most common manoeuvre utilised for all deliveries was a combination of McRoberts and 
Suprapubric pressure (44.4%; n=4 of 9). The birth weight for these infants ranged from 3,695 grams to 
4,595 grams, with three-quarters of these infants (77.8%; n=7 of 9) weighing 4,000-4,499 grams.
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Table 19: Maternal and infants characteristics for deliveries with a reported shoulder dystocia
















Induction of labour 5(55.6)
Mode of delivery










Note: Values are shown as N(%) unless otherwise stated. *Categories are not mutually exclusive. 
26 NEONATAL THERAPEUTIC HYPOTHERMIA IN IRELAND
Infant characteristics
Two-thirds of the infants who received therapeutic hypothermia in 2018 were male (76.8%; n=53 of 
69). In the overall population of births in 2016, 51.3% were male and 48.7% female (Table 20). There 
were three infants who underwent therapeutic hypothermia from multiple births (4.3%). This is similar 
to the proportion of multiples among all births in 2016 (3.8%).9
Table 20: Sex of infants who underwent therapeutic hypothermia in 2016-2018
TH cases  
N=63  
2016
TH cases  
N=77  
2017
TH cases  
N=69  
2018




Male 32(50.8) 48(62.3) 53(76.8) 133(63.6) 51.3%
Female 31(49.2) 29(37.7) 16(23.2) 76(36.4) 48.7%
Note: Values are shown as N(%) unless otherwise stated. 
Gestation at delivery
Figure 3 outlines the gestational age at delivery for infants who underwent therapeutic hypothermia 
in 2018 versus all infants born in 2016. The majority of infants were born between 36 and 41 completed 
weeks gestation (91.1%; n=62 of 68; missing data for one infant). One infant was born at 35 completed 
weeks (1.5%); this infant had a birthweight greater than 1,800 grams.
Figure 3: Gestational age at delivery (weeks) for infants who underwent therapeutic hypothermia in 
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Birthweight at delivery
The mean birthweight for infants who underwent neonatal therapeutic hypothermia in 2018 was 
3,489 grams (Standard Deviation: 547 grams). The birth weight ranged from 2,210 grams to 4,620 
grams. As outlined in Figure 4, almost a quarter of infants weighed 3,000-3,499 grams (21.7%, 
n=15). Over half of infants weighed 3,500 grams or more (55.1%, n=38). A small proportion of infants 
weighed between 1,800 and 2,499 grams (5.8%, n=4).
Figure 4: Distribution of birthweight for infants who underwent therapeutic hypothermia in 2018 
versus all infants born in 2016
Birthweight Centiles
Gestation Related Optimal Weight (GROW) software and coefficients derived from the multiple 
regression analysis of data on 11,072 births in six maternity units in Dublin, Galway, Limerick and 
Belfast in 2008-200914, was used to produce Figure 5, which illustrates the optimal birthweight and 
normal range compared to the recorded birthweights of infants who underwent neonatal therapeutic 
hypothermia in 2018.
The optimal weight and normal range for all gestations are plotted with the actual birthweights of the 
infants in Figure 6. As can also be seen in Table 21, almost one in five of these infants were below the 
lower limit of the normal range (10th centile).
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Figure 5: Optimal birthweight and normal range compared to actual birthweights for infants who 
underwent therapeutic hypothermia in 2018























































When examined by birth weight centile category, the distribution of the TH cohort was broadly 
similar to that expected but there was some evidence of poor fetal growth. Almost 20% of the infants 
(n=12, 17.6%) were below the 10th centile.
Table 21: Birth weight centiles for infants who underwent therapeutic hypothermia in 2016-2018
Centiles
TH cases  
2016  
N=63
TH cases  
2017  
N=77
TH cases  
2018  
N=69
TH cases  
2016-2018  
N=209
<3rd 2(3.2) 6(7.8) 4(5.8) 12(5.7)
3rd to 9th 7(11.1) 11(14.3) 8(11.6) 26(12.4)
10-49th 27(42.9) 28(36.4) 28(40.6) 83(39.7)
50-89th 17(27.0) 24(31.2) 24(34.8) 65(31.1)
>90th 10(15.9) 8(10.4) 5(7.2) 23(11.0)
Note: Values are shown as N(%) unless otherwise stated. 
Diagnosis of fetal growth restriction (FGR)
Data on diagnosis of FGR were recorded for all 69 infants who underwent therapeutic hypothermia in 
2018 (100%). A diagnosis of FGR was reported for five (7.2%) of the 69 infants (Table 22). In keeping 
with previous years, an antenatal diagnosis of FGR (as opposed to diagnosis based on observation at 
delivery or post-mortem) was reported for three of the five infants (60.0%).
Table 22: Diagnosis of fetal growth restriction for infants who underwent therapeutic hypothermia 
in 2016 -2018
TH cases  
2016  
N=63
TH cases  
2017  
N=74*
TH cases  
2018  
N=69
TH cases  
2016-2018  
N=206*
No diagnosis documented 60(95.2) 66(89.2) 64(92.8) 190(92.2)
Diagnosis of fetal growth restriction 3(4.8) 8(10.8) 5(7.2) 16(7.8)
Fetal growth restriction suspected 
antenatally
1 of 3(33.3) 5 of 8(62.5) 3 of 5 (60.0) 9 of 16(56.3)
Note: Values are shown as N(%) unless otherwise stated. *Missing data for three infants.
Resuscitation 
Neonatal or paediatric support was called prior to the delivery of the majority of cases (81.2%; n=56 
of 68; one infant born before arrival). As outlined in Table 23, a Registrar was present at the vast 
majority of births for resuscitation (88.2%; n=60 of 68; data missing for one infant). A Senior House 
Officer (SHO) was also present at the majority of births for resuscitation (92.6%; n=63 of 68). A 
Neonatal Nurse was present at over half of births (52.9%; n=36 of 68) with a Midwife present for one 
in six births for resuscitation (16.1%; n=11 of 68). A Consultant was present for a third of births for 
resuscitation (34.8%; n=48).
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Table 23: Who was present at the time of birth for the resuscitation of infants who underwent 
therapeutic hypothermia in 2016-2018
TH cases  
2016  
N=61*
TH cases  
2017  
N=77
TH cases  
2018  
N=68**
TH cases  
2016-2018  
N=206
Consultant(Neonatology/Paediatrics) 21(34.4) 27(35.1) 28(41.2) 76(36.4)
Registrar 56(91.8) 73(94.8) 60(88.2) 189(91.7)
Senior House Officer 48(78.7) 68(88.3) 63(92.6) 174(83.3))
Neonatal Nurse 22(36.1) 37(48.1) 36(52.9) 95(46.1)
Midwife 16(26.2) 17(22.1) 11(16.1) 44(21.4)
Note: Values are shown as N(%) unless otherwise stated. *Data missing for two infants. **Data missing for one infant.
As indicated in Table 24, at one minute after birth three quarters of infants (75.0%; n=51 of 68) had an 
Apgar score of between zero and three. At ten minutes, infants with an Apgar score of between zero 
and three had reduced to 13.1% (n=8 of 61). At twenty minutes, only six infants had an Apgar score 
recorded; only one of these had a score of eight or greater (16.7%; n=1 of 6).
Table 24: Apgar Scores at 1, 5, 10 and 20 minutes for infants who underwent therapeutic 
hypothermia in 2018
1 minute  
N=68
5 minutes  
N=67
10 minutes  
N=61
20 minutes  
N=6
0 11(16.2) 4(6.0) 2(3.3) 1(16.7)
1 21(30.9) 5(7.5) 1(1.6) 0(0)
2 10(14.7) 10(14.9) 2(3.3) 1(16.7)
3 9(13.2) 5(7.5) 3(4.9) 1(16.7)
4 4(5.9) 14(20.9) 12(19.7) 0(0)
5 3(4.4) 11(16.4) 14(23.0) 1(16.7)
6 7(10.3) 7(10.4) 9(14.8) 0(0)
7 0(0) 5(7.5) 10(16.4) 1(16.7)
8 2(2.9) 2(3.0) 4(6.6) 1(16.7)
9 1(1.5) 2(3.0) 4(6.6) 0(0)
10 0(0) 2(3.0) 0(0) 0(0)
Note: Values are shown as N(%) unless otherwise stated. 
Spontaneous breath was initiated and sustained by half of infants (52.2%; n=36 of 69). Of these infants, 
the age at which spontaneous breathing was sustained was recorded for 33 of the 36 infants (91.7%) 
and began between 1 and 15 minutes (median 4 minutes). 
As illustrated in Table 25, almost all infants were resuscitated in 2018 (94.2%; n=65 of 69). Over half 
of the 69 infants were intubated (59.4%; n=41) which occurred between 1 and 20 minutes (median 5 
minutes). One third of infants had chest compressions (33.3%, n=23), which began at between 1 and 20 
minutes (data missing for three infants). FiO2 was administered to the majority of infants (89.7%, n=61 
of 68; data missing for one infant). 
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Table 25: Resuscitation for infants who underwent therapeutic hypothermia between 2016-2018
TH cases  
2016  
N=63
TH cases  
2017  
N=77
TH cases  
2018  
N=69
TH cases  
2016-2018  
N=209
Spontaneous breath initiated 37(58.7) 37(48.1) 36(52.2) 110(52.6)
Resuscitation 58(92.1) 75(97.4) 65(94.2) 198(94.7)
Intubation 32(50.8) 50(64.9) 41(59.4) 124(59.3)
Chest compressions 19(30.2) 28(36.4) 23(33.3) 70(33.5)
FiO
2
 57(90.5) 72(93.5) 61(89.7) 190(90.9)
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive. 
Table 26: Drugs or fluid treatment administered at birth for infants who underwent therapeutic 
hypothermia in 2016-2018
TH cases  
2016  
N=63
TH cases  
2017  
N=77
TH cases  
2018  
N=69
TH cases  
2016-2018  
N=209
Adrenaline 9(14.3) 9(11.7) 11(15.9) 29(13.9)
Dextrose 2(3.2) 4(5.2) 1(1.4) 7(3.3)
Saline 21(33.3) 21(27.3) 12(17.4) 64(30.6)
O negative blood 5(7.9) 8(10.4) 2(2.9) 15(7.2)
Sodium Bicarbonate 2(3.2) 1(1.3) 1(1.4) 4(1.9)
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive.
One of the key indicators for intrapartum asphyxia is severe metabolic acidosis evident in umbilical 
cord blood at delivery.15 As outlined in Table 27, at delivery, half of infants (58.7%, n=37 of 63; data 
missing for 6 infants) had a pH of 7.0 or lower. The median base deficit was 11.5 (Range: 0.50-26.4) 
from cord blood gases and was 14.7 (Range: 2.60-36.4) from initial infant blood gases. 
Table 27: pH level from cord and initial infant blood gases for infants who underwent therapeutic 
hypothermia in 2018









6.4-6.5 0(0.0) 0(0.0) 1(7.7) 1(6.3)
6.51-6.6 3(4.8) 0(0.0) 0(0.0) 2(12.5)
6.61-6.7 5(7.9) 1(2.7) 1(7.7) 0(0.0)
6.71-6.8 9(14.3) 8(21.6) 1(7.7) 2(12.5)
6.81-6.9 12(19.0) 2(5.4) 1(7.7) 1(6.3)
6.91-7.0 8(12.7) 8(21.6) 4(30.8) 1(6.3)
7.01-7.1 11(17.5) 8(21.6) 1(7.7) 2(12.5)
7.11-7.2 10(15.9) 7(18.9) 3(23.1) 3(18.8)
7.21-7.3 5(7.9) 3(8.1) 1(7.7) 4(25.0)
7.31-7.4 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Note: Values are shown as N(%) unless otherwise stated.
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Assessment for Therapeutic Hypothermia
All 69 infants met one or more criteria for therapeutic hypothermia as outlined in Table 28. Three 
quarters of the women (71.0%), whose infants underwent therapeutic hypothermia in 2018, 
experienced an acute perinatal event. Almost half of infants experienced variable and/or late fetal 
heart rate decelerations during labour (49.3%; n=34). 




≥36 completed weeks gestational age 68(98.6)
Apgar score ≤ 5 at 10 minutes 33(47.8)
Weight ≥ 1800 grams 69(100)
Continued need for PPV or Intubation at 10 mins 41(59.4)
Did an acute perinatal event occur? 49(71.0)
Variable / late fetal heart rate decelerations 34(49.3)
Prolapsed / ruptured / tight nuchal cord 2(2.8)
Uterine Rupture 3(4.3)
Maternal haemorrhage / placental abruption 6(8.6)
Maternal trauma 0(0.0)
Other 11(15.9)
Acidosis present in umbilical cord, or any blood sample within 60 minutes of birth 44(63.8)
Base Deficit >16.0 mmol/L in umbilical cord, or any blood sample, within 60 
minutes of birth
34(49.3)
Note: Values are shown as N(%) unless otherwise stated.
The majority of the infants (97.1%, n=67 of 69) had a diagnosis of encephalopathy based on having an 
altered state of consciousness, (lethargy, stupor or coma). A grade of encephalopathy was assigned 
to 41.8% of infants (n=28 of 67). Table 29 illustrates that almost two thirds of infants were graded as 
moderately encephalopathic during assessment for therapeutic hypothermia (60.7%; n=17).
Table 29: Grade of encephalopathy during assessment for therapeutic hypothermia in 2016-2018
TH cases  
2016  
N=29
TH cases  
2017  
N=40
TH cases  
2018  
N=28
Mild 3(10.3) 8(20.0) 2(7.1)
Moderate 17(58.6) 22(55.0) 17(60.7)
Severe 9(31.0) 10(25.0) 9(32.1)
Note: Values are shown as N(%) unless otherwise stated.
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Transfer to Tertiary Unit
Over half of all infants who were delivered in Ireland in 2016 were born in a tertiary unit (52%).1 
Forty-one of the 69 infants who underwent neonatal therapeutic hypothermia in 2018 were born 
in a tertiary hospital (59.6%; Table 30). Twenty-eight infants required transfer to a tertiary unit 
for therapeutic hypothermia treatment (40.6%). The majority of infants were transported by 
the National Neonatal Transport Programme (67.9%; n=19 of 28) with the remaining nine (32.1%) 
infants being transported by the referring hospital’s team. 
Table 30: Transfer of infants to a tertiary unit for therapeutic hypothermia treatment in 2018
TH cases  
2018  
N=69
Inborn at tertiary unit 41(59.6)
Out-born requiring transfer 28(40.6)
Transferred by the NNTP 19 of 28(67.9)
Transferred by referring hospital’s team 9 of 28(32.1)
Note: Values are shown as N(%) unless otherwise stated.
For almost two-thirds of infants who required transfer, a referral call was made to the tertiary 
cooling centre within two hours of birth (73.9%, n=18 of 23; missing data for 5 infants). A call was 
made between two and three hours for 17.4% of infants requiring transport (n=4 of 23; missing 
data for five infants). 
All 28 infants who required transfer to a tertiary centre, were commenced on Therapeutic 
Hypothermia at the referring hospital within four hours of birth, by means of passive cooling 
(7.1%; 2 of 28) and/or active cooling (92.9%; 26 of 28). All 28 infants who required transfer to a 
tertiary centre were initially passively cooled (see Table 31). Passive cooling was initiated within 
the first hour of birth for over half of infants (53.5%; n=15 of 28). 
Table 31: Age of outborn infants at commencement of therapeutic hypothermia  
(passive and/or active modes) in 2018
Passive Cooling  
N=28
Active Cooling  
N=23
Within 1 hour 15(53.5) 0(0)
1-2 hours 4(14.3) 2(8.7)
2-3 hours 4(14.3) 1(4.3)
3-4 hours 5(17.9) 4(17.3)
4-5 hours (0) 8(34.9)
5-6 hours 0(0) 5(21.8)
Greater than 6 hours 0(0) 3(13.0)
Note: Values are shown as N(%) unless otherwise stated.
34 NEONATAL THERAPEUTIC HYPOTHERMIA IN IRELAND
As illustrated in Figure 7, two-thirds of the infants transferred had a core temperature within the target 
range of 33°C to 34°C on departure from the referring hospital (67.9%, n=19 of 28) with one-quarter of 
infants (25.0%; n=7 of 28) having a core temperature ranging from 34.4°C to 35.9°C. Two infants had a 
core temperature below 33°C.
Figure 7: Temperature (°C) of infant by age (mins) on departure from referring hospital 
Half of infants requiring transfer (42.9%; n=12 of 28) departed the referral hospital within six hours of 
birth (Table 32). Therapeutic Hypothermia was continued during transport in all cases where infants 
were transferred to a tertiary centre (100%; n= 28). The majority of infants transferred by the NNTP were 
changed from passive to active cooling for transport either before or on departure from the referral 
hospital (94.7%; n=18 of 19). Two infants already on active cooling at the referral centre, were changed 
from active to passive cooling during transfer to a tertiary centre by referring hospital teams. All bar two 
of the ten infants who were passively cooled during transfer had reached the optimal core temperature of 
between 33°C and 34°C within six hours of birth. 




Own Hospital Team 
N=9
Departed referring unit within 6 hours 5(26.3) 7(77.8)
Admitted to tertiary unit within 6 hours 0(0.0) 2(22.2)
Note: Values are shown as N(%) unless otherwise stated. *Missing data for two infants.  
**Data missing for three infants. 
Over three-quarters of the 28 infants transferred for neonatal therapeutic hypothermia treatment required 

























Table 33: Management during transfer of infants for therapeutic hypothermia in 2018
NNTP
N=19
Own Hospital Team 
N=9
Respiratory support 17(89.5) 5(55.8)
Ventilation 13 of 15(86.7)* 4 of 5 (80.0)





IV access 19(100) 9(100)
Peripheral 18 of 19(94.7) 8 of 9(88.9)
Umbilical 18 of 19(94.7) 6 of 9(66.7)
Note: Values are shown as N(%) unless otherwise stated. *Data missing for two infants. 
Ninety three percent of the infants requiring transfer to a tertiary unit for therapeutic 
hypothermia treatment were admitted more than six hours after birth (92.9%; 26 of 28). 
One third (32.1%; n=9 of 28) of the infants requiring transfer to a tertiary unit for neonatal 
therapeutic hypothermia treatment were admitted nine or more hours after birth.
As illustrated in Figure 8, the majority of infants had a core temperature within the target 
range of 33°C to 34°C (89.3%, n=25 of 28) on admission to a tertiary unit. While 10.7% (n=3) 
had a core temperature ranging from 34.8°C to 36.3°C, with two of these three infants 
admitted to the tertiary unit before six hours of birth. 
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Initiating of Treatment 
In line with practice guidelines, therapeutic hypothermia should be initiated within six hours of birth 
and should be continued for 72 hours. The optimum core temperature of 33°C to 34°C is targeted 
over this 72-hour period. 
The time the decision to treat the infant with therapeutic hypothermia was not recorded in this 
audit. As illustrated in Table 34, almost all infants were passively cooled before active cooling was 
commenced (92.8%; n=64 of 69). Of these, almost two-thirds of infants were passively cooled within 
the first two hours of birth (60.8%; n=39 of 64). The majority of infants commenced active cooling 
within six hours of birth (85.5%; n=59 of 69). 
Table 34: Age of infant at time of commencement of passive and active cooling for infants who 
underwent therapeutic hypothermia in 2018
Passive Cooling  
N=64
Active Cooling  
N=69
Within 1 hour 28(43.6) 8(11.6)
1-2 hours 11(17.2) 11(15.9)
2-3 hours 6(9.4) 8(11.6)
3-4 hours 5(7.8) 11(15.9)
4-5 hours 3(4.7) 12(17.4)
5-6 hours 0(0.0) 9(13.0)
Greater than 6 hours 1(1.6) 10(14.5)
Note: Values are shown as N(%) unless otherwise stated.
The time when optimum core temperature was reached was recorded for 64 of the 69 infants 
(92.8%). Of these, 79.7% of infants (n=51) were reported to have achieved optimum core temperature 
within 6 hours of birth. Optimum core temperature was achieved for the remaining 13 infants (20.3%) 
between 6 and 16 hours of birth. 
The 72-hour treatment clock should begin when the infant reaches the targeted 33-34°C rectal 
temperature. As illustrated in Figure 9, almost half of infants (46.9%; n=30 of 64, missing data for 
four infants) had their treatment started once they had achieved the optimum core temperature 
range. The remaining infants had begun their 72 hours of TH treatment before the optimum core 
temperature range was achieved (54.1%; n=34 of 64).
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Figure 9: Time infants achieved optimal core temperature in relation to the time TH 
treatment commenced in 2018
Treatment Days 1-3
As outlined in Table 35, almost all infants admitted for neonatal therapeutic hypothermia 
received sedation on Day 1 (98.6%; n=68 of 69), Day 2 (94.2%; n=65 of 69) and Day 3 (89.9%; 
n=62 of 69) of treatment. The vast majority of infants were administered antibiotics on Day 1 
and Day 2 of treatment, with almost half receiving antibiotics on Day 3 (43.5%; n=30 of 69). 
Seven infants required blood products on Day 1 of treatment (10.1%) of which the majority had 
fibrinogen administered (71.4%; n= 5 of 7).
Table 35: Drugs and Volume Replacement Day 1, 2 & 3 in 2018
Day 1 Day 2 Day 3
Sedation 68(98.6) 65(94.2) 62(89.9)
Antibiotics 67(97.1) 64(92.8) 30(43.5)
Anticonvulsants 15((21.7) 10(14.5) 10(14.5)
Inotropes 17(24.6) 17(24.6) 13(18.8)
Blood products 7(10.1) 4(5.8) 2(2.9)
Volume replacement (normal saline) 12(17.4) 3(4.3) 2(2.9)
Other 11(15.9) 10(14.5) 6(8.7)





























Time optimal core temperature achieved
38 NEONATAL THERAPEUTIC HYPOTHERMIA IN IRELAND
As outlined in Tables 36 and 37, a number of diagnostic investigations were undertaken during the 72 
hours of therapeutic hypothermia treatment. 







Acid base parameters 68(98.6) 63(91.3) 55(79.7
Coagulation 32(46.4) 8(11.6) 3(4.3)
Biochemistry 57(82.6) 48(69.6) 36(52.2)
Lumbar puncture 2(2.9) 2(2.9) 2(2.9)
Metabolic Screen 3(4.3) 0(0.0) 2(2.9)
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive. *Data for laboratory 
tests which may have been undertaken during assessment for therapeutic hypothermia were not recorded and 
therefore are not presented here. 
In relation to neuro imaging, 68.1% (n=47) of infants had a cranial ultrasound in the first three days of 
life. Six of these 47 infants underwent more than one cranial ultrasound. Of the 56 cranial ultrasounds 
undertaken, 14 (29.8%) were abnormal. During the three-day period, 1.4% of infants (n=1) underwent 
Magnetic Resonance Imaging (MRI) of the brain in Day 3 (Table 37).







Cranial ultrasound 25(36.2) 16(23.2) 15(21.7)
MRI of the brain 0(0.0) 0(0.0) 1(1.4)
Echocardiography 15(21.7) 8(11.6) 2(2.9)
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive.
SARNAT Scoring
Infants were assigned a SARNAT16 score based on clinical behaviour on Day 1, Day 2 and Day 3 of 
treatment (Table 38). A diagnosis of encephalopathy, consisting of an altered state of consciousness 
(lethargy, stupor or coma) was only assigned to half of infants who had the SARNAT completed over the 
72 hour period of therapeutic hypothermia. As outlined in Table 39, over half of infants were graded as 
moderately encephalopathic on Day 1 (66.7%; n=28 of 42), Day 2 (58.1%; 18 of 36) and Day 3 (51.9%; n=14 
of 36) of treatment. 
Table 38: SARNAT Scoring on Treatment Day 1, 2 & 3 in 2018
Day 1  
N=69 
Day 2  
N=67
Day 3  
N=64
Level of consciousness
Hyperalert 8 (11.6) 4 (6.0)
Lethargic or obtunded 24 (34.8) 18 (26.9) 13 (20.3)
Stupor or Coma 6 (8.7) 4 (6.0) 3 (4.7)
Normal 18 (26.1) 13 (19.4) 15 (23.4)
Undocumented 13 (18.8) 27 (40.3) 33 (51.6)
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Activity
Normal 24 (34.8) 20 (29.9) 17 (26.6)
Decreased 26 (37.7) 20 (29.9) 14 (21.9)
Absent 7 (10.1) 4 (6.0) 3 (4.7)
Undocumented 12 (17.4) 23 (34.3) 31 (48.4)
Neuromuscular Control
Muscle tone Normal 9 (13.0) 11 (15.9) 10 (15.6)
Mild hypotonia 26 (37.7) 12 (17.9) 12 (18.8)
Flaccid 7 (10.1) 4 (5.8) 4 (6.3)
Undocumented 27 (39.1) 40 (59.7) 38 (59.4)
Posture Mild distal flexion 9 (13.0) 3 (4.5) 2 (3.1)
Strong distal flexion 8 (11.6) 8 (11.6) 7 (10.9)
Intermittent decerebration 3 (4.3) 0(0.0) 0(0.0)
Normal 4 (5.8) 2 (3.0) 2 (3.1)
Undocumented 44 (63.8) 53 (79.1) 53 (82.8)
Stretch reflexes Overactive 2 (2.9) 3 (4.5) 3 (4.7)
Decreased or absent 4 (5.8) 1 (1.5) 3 (4.7)
Normal 4 (5.8) 7 (10.4) 4 (6.3)
Undocumented 57 (82.6) 53 (79.1) 52 (81.3)
Complex Reflexes
Suck Weak 16 (23.2) 8 (11.9) 6 (9.4)
Weak or absent 6 (8.7) 7 (10.4) 5 (7.8)
Absent 10 (14.5) 6 (9.0) 4 (6.3)
Normal 13 (18.8) 10 (14.9) 14 (21.9)
Undocumented 22 (31.9) 34 (50.7) 35 (54.7)
Moro Strong; low threshold 0(0.0) 2 (3.0) 0(0.0)
Weak; incomplete high threshold 4 (5.8) 0(0.0) 0(0.0)
Absent 4 (5.8) 3 (4.5) 2 (3.1)
Normal 8 (11.6) 3 (4.5) 4 (6.3)
Undocumented 48 (69.6) 56 (83.6) 57 (89.1)
Tonic Neck Slight 0(0.0) 0(0.0) 0(0.0)
Strong 0(0.0) 0(0.0) 0(0.0)
Absent 0(0.0) 1 (1.5) 1 (1.6)
Normal 1 (1.4) 1 (1.5) 0(0.0)
Undocumented 66 (95.7) 61 (91.0) 63 (98.4)
Autonomic Function
Pupils Mydriasis 3 (4.3) 3 (4.5) 2 (3.1)
Miosis 15 (21.7) 6 (9.0) 1 (1.6)
Variable; often unequal, poor light 
reflex, fixed, dilated 
6 (8.7) 4 (6.0) 2 (3.1)
Normal 16 (23.2) 5 (7.5) 13 (20.3)
Undocumented 28 (40.6) 46 (68.7) 45 (70.3)
Heart rate Tachycardia 0(0.0) 0(0.0) 0(0.0)
Bradycardia 14 (20.3) 11 (16.4) 10 (15.6)
Variable 0(0.0) 1 (1.5) 0(0.0)
Normal 53 (76.8) 54 (80.6) 53 (82.8)
Undocumented 1 (1.4) 0(0.0) 0(0.0)
Seizures None 59 (85.5) 57 (85.1) 0(0.0)
Common; focal or multifocal 10 (14.5) 9 (13.4) 0(0.0)
Uncommon (excluding decerebration) 0(0.0) 0(0.0) 0(0.0)
Normal 0(0.0) 0(0.0) 0(0.0)
Undocumented 0(0.0) 0(0.0) 0(0.0)
Note: Values are shown as N(%) unless otherwise stated. 
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Mild 4(9.5) 3(9.7) 3(11.1)
Moderate 28(66.7) 18(58.1) 14(51.9)
Severe 10(23.8) 10(32.3) 10(37.0)
Note: Values are shown as N(%) unless otherwise stated. 
Over the course of the 72 hours of treatment, amplitude-integrated electroencephalography (aEEG) 
interpretation was documented for two thirds of cases (65.5%). As outlined in Table 40, the number of 
cases where the aEEG was interpreted as severely abnormal reduced from 25.0% (n=12 of 69) on Day 1 to 
13.5% (n=5 of 37) on Day 3. Electrical seizures were identified in 14 of the 69 infants (20.3%) on Day 1, 10 
of the infants (14.5%) on Day 2 and four of all the infants (5.8%) on Day 3. 
Table 40: aEEG interpretation on Treatment Day 1, 2 & 3 in 2018
Day 1  
(n=69)
Day 2  
(n=67)
Day 3  
(n=64)
aEEG interpretation documented 48(69.5) 46(66.7) 37(57.8)
Interpretation
Normal 21 of 48(43.8) 26 of 46(56.5) 23 of 37(62.2)
Abnormal 9 of 48(18.8) 6 of 46(13.0) 3 of 37(8.1)
Moderately abnormal 0(0.0) 6 of 46(13.0) 6 of 37(16.2)
Severely abnormal 12(25.0) 8 of 46(17.4) 5 of 37(13.5)
Electrical seizures 14(20.3) 10(14.9) 4(6.3)
Rewarming
Of the 69 infants who underwent therapeutic hypothermia treatment, 9 infants (13.0%) did not complete 
72 hours of therapeutic hypothermia in 2018. As outlined in Table 41, two-thirds of these infants had their 
care redirected (62.5%; n=5 of 8). 
Table 41: Indications to cease rewarming of infants who underwent TH in 2016-2018 before 72 hours 
completed therapy
TH cases  
N=4  
2016
TH cases  
N=9  
2017
TH cases  
N=8*  
2018
TH cases  
N=21  
2016-2018
Redirection of care 3(75.0) 7(77.8) 5(62.5) 15(71.4)
PPHN 1(25.0) 1(11.1) 2(25.0) 4(19.0)
Sepsis 0(0.0) 1(11.1) 1(12.5) 2(9.5)
Note: Values are shown as N(%) unless otherwise stated. *Missing data for one infant. 
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Excluding the 5 infants whose treatment was ceased, data on rewarming was available for 57 of the 
64 infants (89.1%). As outlined in Table 42, most infants were rewarmed within 12 hours (86.0%; n=49 
of 57) in 2018. During the rewarming period, six of the 57 infants (10.5%) had seizures. Infants were 
rewarmed over periods of between 6 and 18 hours. 
Table 42: Duration of rewarming for infants who underwent therapeutic hypothermia in 2016-2018
TH cases  
N=59  
2016
TH cases  
N=66  
2017
TH cases  
N=57  
2018
TH cases  
N=182  
2016-2018
Up to 12 hours 48(81.4) 50(75.8) 49(86.0) 143(78.6)
13 – 15 hours 4(6.8) 0(0.0) 1(1.8) 5(2.7)
16 – 18 7(11.9) 14(21.2) 7(12.3) 28(15.4)
Greater than 19 hours 0(0.0) 2(3.0) 0(0.0) 2(1.1)
Note: Values are shown as N(%) unless otherwise stated.
Feeding
Data on the introduction of feeding was recorded for 63 of the 69 infants who underwent 
therapeutic hypothermia treatment (91.3%). None of the mothers breastfed on introduction of feed, 
two-thirds of infants were fed with expressed breastmilk (68.1%; n=47) and 28 were fed with formula 
(40.6%). As outlined in Table 43, the majority of infants had feed introduced on Day 4 (52.4%; n=33) 
or Day 5 (23.8%; n=15). The majority of infants reached full oral requirement (92.8%; n=61 of 69). 
Table 43: Age that infants who underwent therapeutic hypothermia in 2016-2018 had feed 
introduced
TH cases  
N=60  
2016
TH cases  
N=66  
2017
TH cases  
N=63  
2018
TH cases  
N=189  
2016-2018
Up to Day 3 6(10.0) 2(3.0) 11(12.7) 19(10.1)
Day 4 17(28.3) 21(31.8) 33(52.4) 71(37.7)
Day 5 25(41.7) 28(42.4) 15(23.8) 68(36.0)
Day 6 8(13.3) 11(16.7) 3(4.8) 22(11.6)
Day 7+ 4(6.6) 4(6.1) 1(1.6) 9(4.8)
Note: Values are shown as N(%) unless otherwise stated.
Of these 63, two-thirds of infants were initially fed with a nasogastric tube (60.3%; n=38). Of 
these, one quarter of infants were fed with a nasogastric tube for less than 24 hours (23.5%; n= 8 
of 34; missing data for 4 infants). As indicated in Table 44, one infant was discharged home with a 
nasogastric tube (2.9%).
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Table 44: Duration of feeding with a nasogastric tube for infants who underwent therapeutic 
hypothermia in 2016-2018
TH cases  
N=30  
2016
TH cases  
N=36  
2017
TH cases  
N=34  
2018
TH cases  
N=90  
2016-2018
Less than 24 hours 9(30.0) 7(19.4) 8(23.5) 24(26.7)
24-47 hours 6(20.0) 7(19.4) 3(8.8) 16(17.8)
48-71 hours 4(13.3) 8(22.2) 1(2.9) 13(14.4)
Greater than 72 hours 8(26.7) 6(16.7) 21(61.8) 25(27.8)
Discharged home with a nasogastric tube 3(10.0) 8(22.2) 1(2.9) 12(13.3)
Note: Values are shown as N(%) unless otherwise stated. 
Specific placental conditions 
Of the 69 infants who underwent TH, the placenta was retained and sent for histological analysis in 
53 of the 69 cases (76.8%). Of these, 41 placental examinations were complete (77.4%, n=41 of 53). 
All 41 completed reports were made available to the NPEC for inclusion in this report. 
Placental disease categories have been divided into subsections and, while numbers in any one 
year are small, it will assist in understanding the relative contribution of placental conditions. In 
particular, a severe fetal inflammatory response is associated with abnormal neonatal neurologic 
findings in cases of chorioamnionitis. 
Abnormal placental findings have been classified in line with recommendations from the publication 
from the international consensus meeting of pathology.18 These are presented under the following 
broad categories: maternal vascular malperfusion (MVM), fetal vascular malperfusion (FVM), cord 
pathology, cord pathology with distal disease, chorioamnionitis, villitis and other. Chorioamnionitis 
was present in a third of cases (34.1%; n=14 of 41). Conditions within the categories of MVM (29.2%, 
n=12 of 41) and FVM (17.0%, n=7 of 41) were also commonly reported (see Table 45).
Placenta pathologies represent the largest category of cause of intrauterine death, with placental 
disease explaining up to 65% of stillbirths.19 With the standardisation of terminology18 the 
prevalence of major pathologic findings becomes clearer as national data accumulates. 
Relatively few studies have examined large numbers of consecutive placentas. One such study, 
conducted in the National Maternity Hospital on 816 placentas20, found what is now termed MVM in 
4.5% of controls and FVM in 2.9% of controls. 
Placentas of infants with NE that underwent TH, showed over a 6-fold increase in FVM (29.2% v 
4.5%) and a similar increase of MVM (17.0% v 2.9%). The prevalence of MVM and FVM in placentas 
of stillborn infants and those needing TH shows the importance of placental examination in all 
cases of perinatal loss and of adverse outcome.
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Table 45: Placental histology findings for infants who underwent neonatal therapeutic hypothermia in 
2016-2018 versus Stillbirths in 2017
TH cases  
N=72  
2016/2017






Maternal Vascular Malperfusion (MVM) 19(26.4) 12 (29.2) 81(34.6)
• Low Grade 11(26.8)
• High Grade 1(2.4)
Fetal Vascular Malperfusion (FVM) 16(22.2) 7 (17.0) 60(25.6)
• Low Grade 4(9.7)
• High Grade 3(7.3)
Any Cord Pathology 14(19.4) 14 (34.0) 54(23.1)
• Isolated 9(21.9)
• Cord Pathology with distal FVM 3 (7.3)
• Cord Pathology with distal High Grade FVM 2 (4.8)
Chorioamnionitis 20(27.8) 14(34.1) 21(9.0)
Chorioamnionitis FIR Stage 2 1(2.4)
Villitis 3(4.2) 4(9.7) 10(4.3)
Other Placental Condition 28(38.9) 12(29.2) 35(15.0)
Normal – 3(7.3) –
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive.
Discharge diagnosis and neonatal death
Of the 69 infants who underwent therapeutic hypothermia treatment, 63 infants (91.3%) had MRI of 
the brain undertaken. The MRI report was available in 59 of the 63 cases (93.7%). The MRI reports were 
assessed by adopting the Barkovich HIE scoring system.21
Adopting the Barkovich HIE scoring system, one quarter (25.4%; n=15 of 59) had an abnormal MRI 
compared to 35% (n=34 of 96) of the infants in 2016/2017 with an abnormal report. The full set of 
Barkovich HIE scores are outlined in Appendix A.
In 12 of the 69 cases no reference was made to HIE on discharge (Table 46). When HIE was referenced at 
discharge, a grade of moderate encephalopathy was assigned to almost half of cases (54.4%; n=31 of 57). 
Table 46: Grade of encephalopathy on discharge in 2016-2018
TH cases  
N=60  
2016
TH cases  
N=68  
2017
TH cases  
N=69  
2018
TH cases  
N=197  
2016-2018
HIE – no grade assigned 27(45.0) 29(42.6) 0(0.0) 56(28.4)
Mild HIE 2(3.3) 3(4.4) 4(5.8) 9(4.6)
Mild-Moderate HIE 1(1.7) 6(8.8) 4(5.8) 11(5.6)
Moderate HIE 23(38.3) 18(26.5) 31(44.9) 72(36.5)
Moderate to Severe HIE 0(0.0) 1(1.5) 3(4.3) 4(2.0)
Severe HIE 6(10.0) 5(7.4) 15(21.7) 26(13.2)
HIE not documented 1(1.7) 6(8.8) 12(17.4) 19(9.6)
Note: Values are shown as N(%) unless otherwise stated.
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The survival rate for the infants who underwent therapeutic hypothermia in 2018 was 93.9%, 
as 7 of the 69 infants died. Three of deaths occurred within 7 completed days of birth and 
were classified as early neonatal deaths (42.9%; n=3 of 7). As outlined in Table 47, three deaths 
occurred after the 7th day and within 28 completed days of birth and were classified as late 
neonatal deaths (42.9%; n=3 of 7). All seven infants had an autopsy performed (100%) as they 
were referred to the coroner. It is important to note that data on the findings of these reports, 
and on the infants’ respective causes of death, were not collected for this report.
Table 47: Perinatal and infant mortality for infants who underwent therapeutic hypothermia in 
2016-2018 
TH cases  
N=6  
2016
TH cases  
N=11  
2017
TH cases  
N=7  
2018
TH cases  
N=24  
2016-2018
Early neonatal death 0(0.0) 5(45.5) 3(42.9) 8(33.3)
Late neonatal death 2(33.3) 4(36.4) 3(42.9) 9(37.5)
Infant death 4(66.7) 2(18.2) 1(14.3) 7(29.2)
Note: Values are shown as N(%) unless otherwise stated.
As outlined in Table 48, first infant blood lactate level was strongly associated with risk of death 
among infants treated with TH. As expected, higher blood lactate scores were associated with 
increased risk of death. Similarly, low Apgar score was an indicator of mortality risk. Twenty-one 
percent of the infants with an Apgar score ≤5 at 10 minutes died, which was 4.8 times higher than 
the risk of deaths among the other infants. 
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Table 48: Maternal and infant characteristics and mortality risk for infants who underwent 










Nulliparous 123 11(8.9) 1.00 (ref.)
Parous 86 13(15.1) 1.69
Pre-existing medical problems
Yes 63 10(15.9) 1.50









<10th 38 3(7.9) 1.03
10-49th 83 13(15.7) 2.04
50-89th 65 5(7.7) 1.00 (ref.)
>90th 23 3(13) 1.70
Sex
Male 133 13(9.8) 1.00 (ref.)
Female 76 11(14.5) 1.48
First infant blood lactate
0 to 4 7 0(0) 0
5 to 14 120 6(5) 1.00 (ref.)
15+ 53 9(17) 3.40
Undocumented 29 9(31) 6.21
Assessment for therapeutic hypothermia 19(9.6)
>36 completed weeks gestational age
Yes 201 24(11.9) 1.00 (ref.)
No 8 0(0) 0
Apgar score ≤ 5 at 10 minutes
Yes 92 19(20.7) 4.83
No 117 5(4.3) 1.00 (ref.)
Weight ≥ 1800 grams
Yes 209 24(11.5)
No 0 0(0)
Continued need for PPV or  
Intubation at 10 mins
Yes 128 22(17.2) 6.96
No 81 2(2.5) 1.00 (ref.)
Did an acute perinatal event occur?
Yes 123 21(17.1) 4.89
No 86 3(3.5) 1.00 (ref.)
Acidosis present in umbilical cord, or any 
blood sample within 60 minutes of birth
Yes 142 22(15.5) 5.19
No 67 2(3) 1.00 (ref.)
Base Deficit >16.0 mmol/L in umbilical 
cord, or any blood sample, within 60 
minutes of birth
Yes 107 20(18.7) 4.77
No 102 4(3.9) 1.00 (ref.)
Diagnosis of encephalopathy during 
assessment for TH
Yes 136 15(11) 0.89
No 73 9(12.3) 1.00 (ref.)
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Appendix A. Barkovich HIE Scores 
Result Watershed (WS) Basal Ganglia/Watershed (BG/W) Basal Ganglia (BG)
Abnormal 4 5 4
Abnormal 4 0 3
Abnormal 2 2 3
Abnormal 2 2 3
Abnormal 2 2 3
Abnormal 2 0 1
Abnormal 2 0 1
Abnormal 2 0 1
Abnormal 1 3 3
Abnormal 0 5 2
Abnormal 0 2 2
Abnormal 0 2 2
Abnormal 0 2 1
Abnormal 0 1 2
Abnormal 0 1 2
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
Normal 0 0 0
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Appendix C.
Link Representatives from each of the Hospital Sites
Cavan General Hospital; Dr Alan Finan
Coombe Women & Infants University Hospital; Dr Martin White/ Ms Anne O’Sullivan
Cork University Maternity Hospital; Dr Peter Filan/ Ms Lucille Bradfield
Kerry General Hospital; Dr Pervaiz/ Ms Maudie Creagh
Letterkenny General Hospital; Dr Mathew Thomas/ Ms Kathleen Greenough
Mayo General Hospital; Ms Andrea McGrail
Midland Regional Hospital, Mullingar; Ms Geraldine Kavanagh
Midland Regional Hospital, Portlaoise; Dr Paul Gallagher/ Ms Anne Blanche
National Maternity Hospital; Prof John Murphy/ Ms Julie McGinley
Our Lady of Lourdes Hospital, Drogheda; Ms Claire Shannon
Portiuncula Hospital; Ms Priscilla Neilan
Rotunda Hospital; Prof Adrienne Foran/ Ms Siobhan Mulvany
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